Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Zimran

Showing results (121-130 of 238) with videos related to

Pageof 24
Sort By:
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Pregnancies in Gaucher disease: a 5-year studyYonatan Elstein, Vered Eisenberg, Sorina Granovsky-Grisaru, et al.
International Journal of Molecular Sciences|April 17, 2025
Sidransky Syndrome-<i>GBA1</i>-Related Parkinson's Disease and Its Targeted TherapiesMajdolen Istaiti, Gilad Yahalom, Mikhal Cohen, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
Blood Cells, Molecules & Diseases|December 21, 2004
Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a modelOri Rogowski, Itzhak Shapira, Ari Zimran, et al.
Journal of Inherited Metabolic Disease|April 8, 2021
Risk of postpartum hemorrhage in multiparous women with Gaucher disease: A call for reconsidering enzyme replacement therapy in all pregnant patientsYael Cohen, Dafna Frydman, Reut Rotem, et al.
Blood Cells, Molecules & Diseases|May 4, 2011
Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reductionDeborah Elstein, A Joseph Foldes, David Zahrieh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Computerized cognitive testing in patients with type I Gaucher disease: effects of enzyme replacement and substrate reductionDeborah Elstein, Judith Guedalia, Glen M Doniger, et al.
Internal Medicine Journal|May 10, 2022
Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher diseaseReut Harel, Israel Gavish, Ariel Aviv, et al.
Orphanet Journal of Rare Diseases|October 14, 2020
Patient reported outcome measures in a large cohort of patients with type 1 Gaucher diseaseTama Dinur, Majdolen Istaiti, Dafna Frydman, et al.
Pageof 24

Showing results (121-130 of 238) with videos related to

Sort By:
Pageof 24
Blood|February 19, 2005
Gaucher disease and cancer incidence: a study from the Gaucher RegistryBarry E Rosenbloom, Neal J Weinreb, Ari Zimran, et al.
American Journal of Obstetrics and Gynecology|February 26, 2004
Pregnancies in Gaucher disease: a 5-year studyYonatan Elstein, Vered Eisenberg, Sorina Granovsky-Grisaru, et al.
International Journal of Molecular Sciences|April 17, 2025
Sidransky Syndrome-<i>GBA1</i>-Related Parkinson's Disease and Its Targeted TherapiesMajdolen Istaiti, Gilad Yahalom, Mikhal Cohen, et al.
Blood Cells, Molecules & Diseases|November 20, 2016
Trio approach reveals higher risk of PD in carriers of severe vs. mild GBA mutationsDavid Arkadir, Tama Dinur, Stephen Mullin, et al.
Blood Cells, Molecules & Diseases|December 21, 2004
Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a modelOri Rogowski, Itzhak Shapira, Ari Zimran, et al.
Journal of Inherited Metabolic Disease|April 8, 2021
Risk of postpartum hemorrhage in multiparous women with Gaucher disease: A call for reconsidering enzyme replacement therapy in all pregnant patientsYael Cohen, Dafna Frydman, Reut Rotem, et al.
Blood Cells, Molecules & Diseases|May 4, 2011
Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reductionDeborah Elstein, A Joseph Foldes, David Zahrieh, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2005
Computerized cognitive testing in patients with type I Gaucher disease: effects of enzyme replacement and substrate reductionDeborah Elstein, Judith Guedalia, Glen M Doniger, et al.
Internal Medicine Journal|May 10, 2022
Enzyme replacement therapy leading to improvement in myeloma indices in a patient with concomitant Gaucher diseaseReut Harel, Israel Gavish, Ariel Aviv, et al.
Orphanet Journal of Rare Diseases|October 14, 2020
Patient reported outcome measures in a large cohort of patients with type 1 Gaucher diseaseTama Dinur, Majdolen Istaiti, Dafna Frydman, et al.
Pageof 24